Department of Otorhinolaryngology - Head and Neck Surgery, Seoul National University Hospital, Seoul National University College of Medicine, Seoul, Republic of Korea.
Department of Otorhinolaryngology - Head and Neck Surgery, Seoul National University Hospital, Seoul National University College of Medicine, Seoul, Republic of Korea.
Oral Oncol. 2019 Feb;89:84-94. doi: 10.1016/j.oraloncology.2018.12.015. Epub 2018 Dec 27.
The aim of this study was to evaluate the treatment outcomes for stage III/IV locally advanced hypopharyngeal squamous cell carcinoma (SCC), comparing induction chemotherapy followed by (chemo)radiotherapy (ICT), definitive chemoradiotherapy (CRT) and surgery-based therapy (SRT).
Two hundred sixty-six patients with stage III/IV locally advanced hypopharyngeal squamous cell carcinoma (SCC) who underwent ICT (n = 74), CRT (n = 53) or SRT (n = 139) from 1997 through 2014 at the Seoul National University Hospital (n = 127) and the Hallym University Medical Center (n = 139) were enrolled in the study. All surgical procedures in the SRT group were performed by a single surgeon to eliminate surgeon bias.
The 5-year disease-free survival (DFS) and overall survival (OS) of all patients (n = 266) were 59.4% and 44%, respectively. The 5-year DFS rates after salvage treatment were 52.7% for ICT, 52.8% for CRT and 65.5% for SRT (p = 0.194). The OS rates were 44.6% for ICT, 39.6% for CRT and 45.3% for SRT group (p = 0.106). The salvage rates were 12.5% for ICT, 15.6% for CRT and 3.8% for SRT group. The final laryngeal preservation rate was significantly lower in the SRT group (44.6%) than in the ICT (71.6%) or CRT (71.7%) groups. All major postoperative complications were significantly higher in the salvage surgery group.
Treatment outcomes in the ICT and CRT groups were comparable to that of the SRT group for stage III/IV hypopharyngeal SCC. However, the relatively low chance of cure and high risk of complications should be taken into account when considering salvage surgery.
本研究旨在评估 III/IV 期局部晚期下咽鳞状细胞癌(SCC)的治疗结果,比较诱导化疗后(放)化疗(ICT)、根治性放化疗(CRT)和基于手术的治疗(SRT)。
1997 年至 2014 年间,首尔国立大学医院(n=127)和翰林大学医疗中心(n=139)共招募了 266 名接受 ICT(n=74)、CRT(n=53)或 SRT(n=139)的 III/IV 期局部晚期下咽鳞状细胞癌(SCC)患者。所有 SRT 组的手术均由一名外科医生进行,以消除外科医生的偏见。
所有患者(n=266)的 5 年无病生存率(DFS)和总生存率(OS)分别为 59.4%和 44%。ICT、CRT 和 SRT 组的挽救性治疗后 5 年 DFS 率分别为 52.7%、52.8%和 65.5%(p=0.194)。ICT、CRT 和 SRT 组的 OS 率分别为 44.6%、39.6%和 45.3%(p=0.106)。ICT、CRT 和 SRT 组的挽救率分别为 12.5%、15.6%和 3.8%。SRT 组最终保喉率明显低于 ICT(71.6%)或 CRT(71.7%)组(44.6%)。所有主要术后并发症在挽救手术组中明显更高。
对于 III/IV 期下咽 SCC,ICT 和 CRT 组的治疗结果与 SRT 组相当。然而,在考虑挽救性手术时,应考虑到治愈机会相对较低和并发症风险较高的问题。